A Pilot to Develop and Test an Interactive Computer-adaptive Chronic Kidney Disease Education Program for Hospitalized African American Patients (I-C-CKD)
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney disease (CKD). The main question it aims to answer are: does computerized adaptive education (CAE) increase patients' knowledge about CKD self-care and renal replacement therapy (RRT) options compared to usual care (UC) and will CAE will be increase patients' intent to participate in CKD self-care and RRT preparation compared to UC
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• African-American inpatients
• Ages 18-70
• estimated glomerular filtration rate (eGFR)\<45
• Enrolled in the Hospitalist Project
Locations
United States
Illinois
University of Chicago Medical Center
RECRUITING
Chicago
Contact Information
Primary
Milda Saunders, MD
msaunder@bsd.uchicago.edu
7737025941
Backup
Akilah King, MSW
Akilah.King@bsd.uchicago.edu
Time Frame
Start Date: 2023-05-31
Estimated Completion Date: 2026-09
Participants
Target number of participants: 120
Treatments
Active_comparator: Usual Care
The research assistant (RA) will use tablet to give participants baseline General Health Knowledge and Intent survey and leave printed patient education materials about general health maintenance. In the initial consent, pre-intervention survey and education materials, investigators will not provide CKD specific knowledge or inform participants about their CKD.
Experimental: Computerized Patient Education
The RA will assist participants in starting the computer program and encourage review of the advanced CKD education module. The computer-adaptive education module will alter the content of education topics based on some preliminary participant information.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: University of Chicago